Europe CRISPR Gene Editing market was valued at $397.7 million in 2021 and will grow by 27.3% annually over 2021-2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid COVID-19 pandemic.
Highlighted with 38 tables and 54 figures, this 125-page report “Europe CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe CRISPR Gene Editing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe CRISPR Gene Editing market in every aspect of the classification from perspectives of Offering, Application, End User, and Country.
Based on Offering, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• CRISPR Products
o Kits & Enzymes
Vector-Based Cas9
DNA-Free Cas9
o Databases & Libraries
o Design Tools
o Antibodies
o CRISPR Plasmid & Vector
o Other Products
• CRISPR Services
o gRNA Design & Vector Construction
o Cell Line Engineering
o Microbial Gene Editing
o DNA Synthesis
o Other Services
Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Biomedical Research & Therapy
o Gene Therapy
o Drug Discovery
o Diagnostics
o Other Biomedical Applications
• Agriculture
• Industrial Use
• Other Applications
By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pharmaceutical Companies
• Biotechnology Companies
• Academic Institutions & Research Centers
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Netherlands
• Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of key national markets by Offering, Application, and End User, over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abcam, Inc.
Agilent Technologies, Inc.
Applied StemCell, Inc.
Caribou Biosciences, Inc.
Cellecta, Inc.
CRISPR Therapeutics AG
Editas Medicine, Inc.
GeneCopoeia, Inc.
GeneScript Biotech Corporation
Horizon Discovery Group PLC
Integrated DNA Technologies, Inc.
Intellia Therapeutics Inc.
Lonza Group Ltd.
Merck KGaA
New England Biolabs, Inc.
Origene Technologies, Inc.
Rockland Immunochemicals, Inc.
Synthego Corporation
System Biosciences LLC
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
ToolGen, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 38
2.5 Porter’s Fiver Forces Analysis 42
3 Segmentation of Europe Market by Offering 46
3.1 Market Overview by Offering 46
3.2 CRISPR Products 48
3.2.1 Kits & Enzymes 50
3.2.2 Databases & Libraries 51
3.2.3 Design Tools 52
3.2.4 Antibodies 53
3.2.5 CRISPR Plasmid & Vector 54
3.2.6 Other Products 55
3.3 CRISPR Services 56
3.3.1 gRNA Design & Vector Construction 58
3.3.2 Cell Line Engineering 59
3.3.3 Microbial Gene Editing 60
3.3.4 DNA Synthesis 61
3.3.5 Other Services 62
4 Segmentation of Europe Market by Application 63
4.1 Market Overview by Application 63
4.2 Biomedical Research & Therapy 65
4.2.1 Gene Therapy 67
4.2.2 Drug Discovery 68
4.2.3 Diagnostics 69
4.2.4 Other Biomedical Applications 70
4.3 Agriculture 71
4.4 Industrial Use 72
4.5 Other Applications 73
5 Segmentation of Europe Market by End User 74
5.1 Market Overview by End User 74
5.2 Pharmaceutical Companies 76
5.3 Biotechnology Companies 77
5.4 Academic Institutions & Research Centers 78
5.5 Other End Users 79
6 European Market 2021-2031 by Country 80
6.1 Overview of European Market 80
6.2 Germany 83
6.3 U.K. 85
6.4 France 87
6.5 Spain 89
6.6 Italy 91
6.7 Netherlands 93
6.8 Rest of European Market 95
7 Competitive Landscape 97
7.1 Overview of Key Vendors 97
7.2 New Product Launch, Partnership, Investment, and M&A 101
7.3 Company Profiles 102
Abcam, Inc. 102
Agilent Technologies, Inc. 104
Applied StemCell, Inc. 105
Caribou Biosciences, Inc. 106
Cellecta, Inc. 107
CRISPR Therapeutics AG 108
Editas Medicine, Inc. 109
GeneCopoeia, Inc. 110
GeneScript Biotech Corporation 111
Horizon Discovery Group PLC 112
Integrated DNA Technologies, Inc. 113
Intellia Therapeutics Inc. 114
Lonza Group Ltd. 115
Merck KGaA 116
New England Biolabs, Inc. 117
Origene Technologies, Inc. 118
Rockland Immunochemicals, Inc. 119
Synthego Corporation 120
System Biosciences LLC 121
Takara Bio, Inc. 122
Thermo Fisher Scientific, Inc. 123
ToolGen, Inc. 124
RELATED REPORTS 125
List of Tables:
Table 1. Snapshot of Europe CRISPR Gene Editing Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 23
Table 3. Developing Roadmap of CRISPR Technology 27
Table 4. Private and Public Companies Investment in CRISPR Technology 28
Table 5. Comparison of CRISPR with Other Gene Editing Technologies 31
Table 6. World Health Spending by Region, $ bn, 2013-2020 34
Table 7. Main Product Trends and Market Opportunities in Europe CRISPR Gene Editing Market 38
Table 8. Europe CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 46
Table 9. Europe CRISPR Gene Editing Market: CRISPR Products by Type, 2021-2031, $ mn 49
Table 10. Europe CRISPR Gene Editing Market: Kits & Enzymes by Type, 2021-2031, $ mn 50
Table 11. Europe CRISPR Gene Editing Market: CRISPR Services by Type, 2021-2031, $ mn 57
Table 12. Europe CRISPR Gene Editing Market by Application, 2021-2031, $ mn 63
Table 13. Europe CRISPR Gene Editing Market: Biomedical Research & Therapy by Type, 2021-2031, $ mn 66
Table 14. Europe CRISPR Gene Editing Market by End User, 2021-2031, $ mn 74
Table 15. Europe CRISPR Gene Editing Market by Country, 2021-2031, $ mn 82
Table 16. Germany CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 84
Table 17. Germany CRISPR Gene Editing Market by Application, 2021-2031, $ mn 84
Table 18. Germany CRISPR Gene Editing Market by End User, 2021-2031, $ mn 84
Table 19. U.K. CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 86
Table 20. U.K. CRISPR Gene Editing Market by Application, 2021-2031, $ mn 86
Table 21. U.K. CRISPR Gene Editing Market by End User, 2021-2031, $ mn 86
Table 22. France CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 88
Table 23. France CRISPR Gene Editing Market by Application, 2021-2031, $ mn 88
Table 24. France CRISPR Gene Editing Market by End User, 2021-2031, $ mn 88
Table 25. Spain CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 90
Table 26. Spain CRISPR Gene Editing Market by Application, 2021-2031, $ mn 90
Table 27. Spain CRISPR Gene Editing Market by End User, 2021-2031, $ mn 90
Table 28. Italy CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 92
Table 29. Italy CRISPR Gene Editing Market by Application, 2021-2031, $ mn 92
Table 30. Italy CRISPR Gene Editing Market by End User, 2021-2031, $ mn 92
Table 31. Netherlands CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 94
Table 32. Netherlands CRISPR Gene Editing Market by Application, 2021-2031, $ mn 94
Table 33. Netherlands CRISPR Gene Editing Market by End User, 2021-2031, $ mn 94
Table 34. CRISPR Gene Editing Market in Rest of Europe by Country, 2021-2031, $ mn 96
Table 35. Breakdown of World Market by Key Vendor, 2021, % 99
Table 36. Abcam, Inc.: Company Snapshot 102
Table 37. Abcam, Inc.: Business Segmentation 103
Table 38. Abcam, Inc.: Product Portfolio 103
